​CE for Pharmacists: The X-Factor: Overcoming DOAC Barriers in OAC Eligible Patients

by Christi Ann Albert, PharmD, BCPS, Kristina Yokes, PharmD, BCACP, Anne E. Rose, PharmD 

Learning Objectives

• Identify patient populations eligible for DOACs and when DOAC use is controversial or contraindicated.
• Compare and contrast characteristics of VKAs with DOACs.
• Apply national organizational guidelines for AF and VTE when choosing an anticoagulant.
• Describe ways to overcome cost barriers for DOACs.

Keywords: Venous Thromboembolism, Warfarin, Atrial Fibrillation, Anticoagulants, Vitamin K, Drug Interactions

​Download PDF 

2022 July/August Table of Contents